Robert M. Gervis, Director at ASPEN AEROGELS INC (ASPN), bought 7,912 shares at $3.95 ($31K) on 2017-03-22, disclosed to the SEC on 2017-03-23.
Scheduled purchase ($31k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.95 | 2,800 | $11K | 35.4% |
| 2 | $3.96 | 2,612 | $10K | 33.1% |
| 3 | $3.94 | 1,100 | $4K | 13.9% |
| 4 | $3.95 | 1,400 | $6K | 17.7% |
| Total | $3.95 avg | 7,912 | $31K | 100% |
| Filing → |
| ASPN | BUY | 2017-05-08 | $3K | — | Filing → |
| ASPN | BUY | 2017-05-04 | $2K | — | Filing → |
| ASPN | BUY | 2017-05-02 | $1K | — | Filing → |